Zdrowie i gospodarka · 19/08/2011
FDA Releases Draft Guidance for Clinical Trial Imaging Endpoints
The Food and Drug Administration (FDA) has made available a draft guidance document, titled 'Standards for Clinical Trial Imaging Endpoints,' aimed at helping pharmaceutical companies properly collect and record imaging data in clinical trials of new treatments.
Source: Federal Register — Health and Human ServicesOpen original release →